BR100 Increased By (0.81%)
BR30 Increased By (1.07%)
KSE100 Increased By (0.57%)
KSE30 Increased By (0.59%)
BECO 5.95 Increased By ▲ 0.18 (3.12%)
BML 53.08 Increased By ▲ 0.08 (0.15%)
BOP 34.39 Increased By ▲ 0.40 (1.18%)
CNERGY 8.13 Increased By ▲ 0.02 (0.25%)
DCL 12.36 Increased By ▲ 0.16 (1.31%)
FCCL 53.53 Increased By ▲ 0.70 (1.33%)
FCSC 5.25 Increased By ▲ 0.18 (3.55%)
FFL 18.07 Increased By ▲ 0.12 (0.67%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 10.84 Decreased By ▼ -0.04 (-0.37%)
KEL 8.15 Increased By ▲ 0.13 (1.62%)
KOSM 5.50 Decreased By ▼ -0.02 (-0.36%)
MLCF 87.65 Increased By ▲ 1.14 (1.32%)
NBP 187.00 Increased By ▲ 1.84 (0.99%)
PACE 10.73 Increased By ▲ 0.15 (1.42%)
PAEL 39.90 Increased By ▲ 0.48 (1.22%)
PIAHCLA 26.15 Decreased By ▼ -0.07 (-0.27%)
PIBTL 17.10 Increased By ▲ 0.43 (2.58%)
PPL 229.95 Increased By ▲ 1.77 (0.78%)
PRL 34.89 Increased By ▲ 0.21 (0.61%)
PTC 67.60 Increased By ▲ 2.27 (3.47%)
SEARL 91.30 Increased By ▲ 1.17 (1.3%)
SSGC 26.90 Increased By ▲ 0.30 (1.13%)
TELE 8.75 Increased By ▲ 0.47 (5.68%)
THCCL 59.00 Increased By ▲ 0.50 (0.85%)
TPLP 8.73 Increased By ▲ 0.51 (6.2%)
TREET 24.71 Increased By ▲ 0.18 (0.73%)
TRG 70.13 Increased By ▲ 0.42 (0.6%)
WAVES 10.04 Increased By ▲ 0.10 (1.01%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
Topic

clinical trials

4G Clinical raises over $230mn growth equity from Goldman Sachs

4G Clinical raises over $230mn growth equity from Goldman Sachs

Published 29 Jun, 2021 06:13pm
  • Neither one of us was going to go back and get a PhD in biochemistry and discover a molecule, but the way that we're intending to help is through technology, through our business practices, you know, removing bottlenecks in the clinical trial process.
China's Sinovac vaccine 67pc effective against symptomatic infection: Chile report

China's Sinovac vaccine 67pc effective against symptomatic infection: Chile report

Published 16 Apr, 2021 07:39pm
  • The vaccine was 85% effective in preventing hospitalizations and 80% effective in preventing deaths, the government said in a report prepared by the Chilean health ministry.
  • Chile's study examined CoronaVac's effectiveness among 10.5 million people, again looking both at people who had been vaccinated and those who had not.
Valneva's COVID-19 shot set for Phase Three trial this month

Valneva's COVID-19 shot set for Phase Three trial this month

Updated 06 Apr, 2021 07:29pm
  • The vaccine, Valneva said, was "generally safe and well tolerated across all dose groups tested, with no safety concerns identified by an independent Data Safety Monitoring Board".
  • "Based on the data assessed, the company has decided to advance the high dose into the phase 3 clinical trial. Other trials, including booster trials, involving antigen sparing doses will also be evaluated," Valneva said.
COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population

COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population

Published 11 Jan, 2021 01:24pm
  • Pakistan is still waiting for the United Nation’s Covax mechanism to receive around 45 million free vaccine doses that will cover country’s 20 percent population
  • Many states including Turkey, Columbia, Bangladesh, Malaysia and India have already struck deals with different COVID-19 vaccine manufacturing firms
  • The Pakistan government has allowed the private sector players to procure vaccine from anywhere in the world and get registered with DRAP
Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials

Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials

Published 31 Dec, 2020 03:04pm
  • “I have presented myself for the vaccine trial as secretary health,” says Dr Kazim Jatoi.
  • Several prominent public figures including Punjab Governor Chaudhry Sarwar and his wife have volunteered to be vaccinated in clinical trials of a Chinese vaccine being conducted in the country.
Loading...